# Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain

> **NCT03254459** · PHASE2 · COMPLETED · sponsor: **INSYS Therapeutics Inc** · enrollment: 100 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Buprenorphine Sublingual Spray
- **DRUG:** Morphine
- **DRUG:** Oxycodone Hydrochloride
- **DRUG:** Zofran

## Key facts

- **NCT ID:** NCT03254459
- **Lead sponsor:** INSYS Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-12
- **Primary completion:** 2017-11-13
- **Final completion:** 2017-11-13
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2018-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03254459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03254459, "Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03254459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*